Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human IGFBP6 Antibodies:
anti-Mouse (Murine) IGFBP6 Antibodies:
anti-Rat (Rattus) IGFBP6 Antibodies:
Go to our pre-filtered search.
Human Polyclonal IGFBP6 Primary Antibody for FACS, IHC (p) - ABIN390729
Guey, García-Closas, Murta-Nascimento, Lloreta, Palencia, Kogevinas, Rothman, Vellalta, Calle, Marenne, Tardón, Carrato, García-Closas, Serra, Silverman, Chanock, Real, Malats: Genetic susceptibility to distinct bladder cancer subphenotypes. in European urology 2010
Human Polyclonal IGFBP6 Primary Antibody for ELISA, WB - ABIN409084
Cheung, Vesey, Cotterill, Douglas, Gobe, Nicol, Johnson: Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas. in International journal of urology : official journal of the Japanese Urological Association 2005
Human Polyclonal IGFBP6 Primary Antibody for IF (p), IHC (p) - ABIN753298
Yuan, Han, Cong, Ge, Ma, Dai, Li, Bi: Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity. in International journal of nanomedicine 2014
We found that IGFBP6 and SATB2 (show SATB2 Antibodies) were significantly down-regulated in HIV-infected CEM*174 cells and 3 different cohorts of HIV/AIDS patients while their promoters were predominantly hyper-methylated compared with normal controls.
IGFBP6 attenuation in ACTH (show POMC Antibodies)-secreting pituitary adenomas is associated with tumor growth, through activation of PI3K (show PIK3CA Antibodies)-AKT (show AKT1 Antibodies)-mTOR (show FRAP1 Antibodies) pathway
CCL-18 (show CCL18 Antibodies) and IGFBP-6 were identified as new potential serum biomarkers for prostate cancer.
When the concentrations of IGFBP-6 or KNG1 (show KNG1 Antibodies) were greater than 98.5 pg/ml or 88.5 ng/ml, respectively, they predicted the proliferative vitreoretinopathy prognosis.
Our results indicate that IGF2 and IGFBP6 appear to govern various regulatory feedback mechanisms in periodontal ligament cells
Data indicate that IGFBP-6 binds to prohibitin-2 (show PHB2 Antibodies) on the cell membrane, and knockdown of the latter abrogates IGFBP-6-induced migration.
This is the first report to implicate IGFBP-6 as a suppressor of cellular proliferation and IGF-II as an inducer of cellular contractility in this connective tissue disease.
Review of the IGF system in physiology and disease with a focus on the regulation and actions of IGFBP-6, and its potential roles in cancer cells.
These results suggest that the expression of IGFBP-6 in vascular endothelial cells is up-regulated by hypoxia and IGFBP-6 inhibits angiogenesis in vitro and in vivo
IGFBP-6 acts as a inhibitory mediator of thyroid hormone (show PTH Antibodies) effects in osteoblast differentiation
Genome-wide methylation analysis showed that two genes with hypomethylated promoters, Igfbp6 and Foxs1, are upregulated in GDX (show UBL4A Antibodies)-induced adrenocortical neoplasms.
Igfbp-6 is a target of sonic hedgehog (show SHH Antibodies) signaling in the urogenital sinus
These results reveal a novel function for MMP-9 (show MMP9 Antibodies) and -12 in developmental myelination likely through regulating IGF-1 (show IGF1 Antibodies) bioavailability.
Report multiple post-translational modifications of mouse insulin-like growth factor binding protein-6 expressed in epithelial Madin-Darby canine kidney cells.
high-affinity IGF binding ptotein with substantially greater affinity for insulin-like growth factor-II (IGF-II) than IGF-I
insulin-like growth factor binding protein 6
, IGF binding protein 6
, IGF-binding protein 6
, insulin-like growth factor-binding protein 6
, INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6 PRECURSOR (IGFBP-6) (IBP-6) (IGF-BINDING PROTEIN 6)